欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/3845/001
药品名称Batrevac Tetra
活性成分
    • A/California/07/2009(H1N1)v 15.0 µg
    • A/Texas/50/2012 (H3N2) like virus 15.0 µg
    • B/Brisbane/60/2008 15.0 µg
    • B/Massachusetts/2/2012-like virus 15.0 µg
剂型SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE
上市许可持有人Abbott Biologicals B.V. C.J. van Houtenlaan 36 Weesp the Netherlands
参考成员国 - 产品名称Netherlands (NL)
Batrevac Tetra, suspensie voor injectie in voorgevulde spuit 0,5 ml
互认成员国 - 产品名称
    • Germany (DE)
    • United Kingdom (Northern Ireland) (XI)
    • Austria (AT)
      FluVaccinol Subunit Tetra Injektionssuspension in einer Fertigspritze
许可日期2017/07/10
最近更新日期2023/07/12
药物ATC编码
    • J07BB02 influenza, inactivated, split virus or surface antigen
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Multiple (Copy) Application
  • TypeLevel3：Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4：Biological: Vaccine
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase